Ms. Smith has just won the “Sheriff of Wall Street’s” heart
, but every other investor is in officially love with Mr. Jones
(INDEXDJX:.DJI). Dow Industrials, which finished the week atop a new inflation-adjusted peak at long last, took center stage as US stocks surged on market-friendly action from the Fed. The still-married “Love guv,” a.k.a. “Client Number 9,″ likely went on Ashley Madison
in search of, well, Love Potion Number 9
. He may have been better advised to instead employ IAC/InterActiveCorp
(NASDAQ:IACI), in a week when the Match.com owner jumped 12.20% to a historic high. The stock fared far better than its communications mouthpiece, fired on Friday after becoming yet another high-profile person to send an idiotic Tweet. (“Going to Africa. Hope I don’t get AIDS. Just kidding. I’m white!
“) In a delicious irony, that same day Twitter
(NYSE:TWTR) surged 4.38% to a post-IPO best. Robert Ford could give the unfortunate Justine Sacco a run for her money for foot-in-mouth disease
. An affliction that is apparently contagious, to judge by Ford Motor
(NYSE:F) falling 7.1% for its worst week since May 2012. BlackBerry
(NASDAQ:BBRY), long left for dead, rebounded a remarkable 18.75%. Its products were increasingly seen as old hat but, when the humble fax machine is suddenly all the rage
on either side of the nuclear-armed 38th parallel, the Canadian company now seems cutting edge.
It’s slim pickings for earnings announcements at the start of this holiday-shortened week, but Mechel Steel
(NYSE:MTL) released results earlier this morning. In terms of economic events that may move US stock markets today, the University of Michigan’s final figure for December consumer confidence is predicted to improve from its preliminary pace at 9:55 a.m. Eastern.
(NASDAQ:ARIA): ARIA is increased to Outperform from Perform by William Blair. This follows news that the Food and Drug Administration (FDA) will allow the firm to restart marketing of its leukemia drug Iclusig.
(NYSE:BPO): Citing an increasingly attractive valuation, Stifel boosts BPO to Hold from Sell.
(NASDAQ:FIVE): Five Below is now Outperform from Neutral at Credit Suisse. As a result, Five Below stock is currently showing strength ahead of this morning’s opening bell.
(NASDAQ:FTNT): Robert W. Baird raises its recommendation to Outperform from Neutral and also increases its price objective by $1 to $25. Catalysts include new blood in the executive suite and brighter revenue prospects.
(NASDAQ:HTLD): BB&T Capital Markets hoists HTLD to Buy from Hold.
(NYSE:KBH): Shares are now Neutral from Sell at Citigroup.
(NASDAQ:LPSN): The Benchmark Company lifts LivePerson to Buy from Hold. Its target price on LivePerson stock is $17.
(NASDAQ:SRPT): Piper Jaffray juices its assessment to Neutral from Underweight.
(NASDAQ:SKUL): More good news for Skullcandy, whose stock surged some 11.44% last week. Roth Capital raises its recommendation to Buy from Neutral, sending shares up another 4.80% as we speak.
(NYSE:TOO): JP Morgan takes TOO to Overweight from Neutral.
(NASDAQ:UTHR): Shares are now Neutral from Underweight, also at JP Morgan.
(NASDAQ:XLNX): Drexel Hamilton hoists the technology stock to Buy from Hold.
(See also: New Stock Coverage: Extended Stay America Has Room at the Inn This Christmas
and Stock Downgrades: Trouble Brewing in the BlackBerry Patch
No positions in stocks mentioned.
The information on this website solely reflects the analysis of or opinion about the performance of securities and financial markets by the writers whose articles appear on the site. The views expressed by the writers are not necessarily the views of Minyanville Media, Inc. or members of its management. Nothing contained on the website is intended to constitute a recommendation or advice addressed to an individual investor or category of investors to purchase, sell or hold any security, or to take any action with respect to the prospective movement of the securities markets or to solicit the purchase or sale of any security. Any investment decisions must be made by the reader either individually or in consultation with his or her investment professional. Minyanville writers and staff may trade or hold positions in securities that are discussed in articles appearing on the website. Writers of articles are required to disclose whether they have a position in any stock or fund discussed in an article, but are not permitted to disclose the size or direction of the position. Nothing on this website is intended to solicit business of any kind for a writer's business or fund. Minyanville management and staff as well as contributing writers will not respond to emails or other communications requesting investment advice.
Copyright 2011 Minyanville Media, Inc. All Rights Reserved.